Pfizer's COVID vaccine should be approved for kids 5 to 11 in the U.S., advisory panel says

An influential advisory panel voted Tuesday that all children ages five to 11 in the U.S. should get Pfizer-BioNTech's pediatric COVID-19 shots, putting the country on the brink of a major expansion of vaccinations — and a final decision is expected within hours.